He has coordinated the national defense of several
major pharmaceutical litigations and has led teams defending manufacturers of vaccines, blood products, automobiles, asbestos - containing products, toys and many other products.
Not exact matches
Served as
litigation counsel for
major pharmaceutical company in test case of nationwide significance, involving allegations of Medicaid fraud.
Serve as national counsel for a
major pharmaceutical company in all aspects of its HRT
litigation.
He has extensive experience in representing a
major media company, financial institutions, brand name
pharmaceutical manufacturers, accounting firms, law firms, and a variety of other companies and professionals in federal and state
litigation, including in matters involving antitrust law, securities law, corporate governance,
pharmaceutical pricing, contract disputes, accountants liability, legal malpractice and communications law.
Before joining Arent Fox in 2004, Ricardo was a partner in a
major law firm in the city of Caracas, Venezuela where he represented various
pharmaceutical, food, and entertainment companies doing business in Venezuela and South America in areas including foreign investment requirements and compliance, regulatory compliance with focus on food and
pharmaceuticals, and intellectual property — namely trademark protection and
litigation, data access, and privacy and patent
litigation (mostly design patent).
Mr. Girard currently serves on the leadership team in the Target and Sony data breach actions; serves as lead counsel in derivative
litigation on behalf of Wal - Mart shareholders arising out of alleged bribery in Mexico, lead counsel for commodities investors in
litigation arising out of the collapse of a commodities futures merchant, and lead counsel in a multi-district «pay for delay» antitrust proceeding against
major pharmaceutical companies.
Our present and recent engagements as national coordinating counsel in
major pharmaceutical and medical device
litigation involve numerous products for many of the world's largest
pharmaceutical manufacturers.
Legal Times: «Wednesday's decisive Supreme Court ruling against Wyeth in a landmark
pharmaceutical product liability case may also close off a
major front in a hard - fought battle by businesses and the Bush administration to insulate national corporations from state tort
litigation.»
Kathleen's IP
litigation practice focuses on patent, trademark, and copyright cases and disputes for clients ranging from
major pharmaceutical companies to start - ups and senior executives.